Trust Point Inc. Takes $874,000 Position in Integer Holdings Co. (NYSE:ITGR)

Trust Point Inc. purchased a new stake in Integer Holdings Co. (NYSE:ITGR - Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm purchased 8,819 shares of the medical equipment provider's stock, valued at approximately $874,000.

Other institutional investors and hedge funds have also made changes to their positions in the company. LVZ Inc. purchased a new position in Integer during the 4th quarter worth $239,000. Blue Trust Inc. grew its stake in Integer by 483.3% during the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider's stock worth $45,000 after buying an additional 377 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in Integer during the 4th quarter valued at about $1,375,000. Raymond James & Associates grew its stake in Integer by 20.3% during the 4th quarter. Raymond James & Associates now owns 48,946 shares of the medical equipment provider's stock valued at $4,850,000 after purchasing an additional 8,246 shares during the last quarter. Finally, Legacy Wealth Asset Management LLC purchased a new stake in Integer during the 4th quarter valued at about $239,000. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on ITGR shares. Benchmark boosted their price target on Integer from $105.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, March 28th. CL King began coverage on Integer in a report on Thursday, March 14th. They issued a "buy" rating and a $137.00 price objective for the company. Finally, KeyCorp decreased their price objective on Integer from $125.00 to $123.00 and set an "overweight" rating for the company in a report on Friday, February 16th. Three research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $114.40.

Integer Stock Down 1.1 %

Shares of NYSE:ITGR traded down $1.23 on Thursday, hitting $115.01. 835,708 shares of the company's stock were exchanged, compared to its average volume of 292,897. The company has a market capitalization of $3.84 billion, a PE ratio of 42.76, a P/E/G ratio of 1.45 and a beta of 1.10. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.71 and a current ratio of 2.80. Integer Holdings Co. has a 1-year low of $69.40 and a 1-year high of $118.15. The firm's 50-day moving average is $108.57 and its 200 day moving average is $95.46.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.05. The business had revenue of $413.15 million during the quarter, compared to the consensus estimate of $409.04 million. Integer had a return on equity of 10.80% and a net margin of 5.68%. The company's revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.11 EPS. Sell-side analysts predict that Integer Holdings Co. will post 5.28 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.